IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus

Abstract Background Most patients with systemic lupus erythematosus (SLE) have IgG autoantibodies against the RNA-binding p40 (ORF1p) protein encoded by the L1 retroelement. This study tested if these autoantibodies are also present in children with pediatric SLE (pSLE) and if the p40 protein itself...

Full description

Bibliographic Details
Main Authors: Kennedy C. Ukadike, Kathryn Ni, Xiaoxing Wang, Martin S. Taylor, John LaCava, Lauren M. Pachman, Mary Eckert, Anne Stevens, Christian Lood, Tomas Mustelin
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-021-02538-3
id doaj-ae78da3b6b924d6eb8237d69e80b45d1
record_format Article
spelling doaj-ae78da3b6b924d6eb8237d69e80b45d12021-05-30T11:50:48ZengBMCArthritis Research & Therapy1478-63622021-05-0123111310.1186/s13075-021-02538-3IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosusKennedy C. Ukadike0Kathryn Ni1Xiaoxing Wang2Martin S. Taylor3John LaCava4Lauren M. Pachman5Mary Eckert6Anne Stevens7Christian Lood8Tomas Mustelin9Division of Rheumatology, University of WashingtonDivision of Rheumatology, University of WashingtonDivision of Rheumatology, University of WashingtonMassachusetts General Hospital, Boston, and Whitehead InstituteThe Rockefeller UniversityAnn & Robert H. Lurie Children’s Hospital of Chicago, and Northwestern University Feinberg School of MedicineSeattle Children’s HospitalDivision of Rheumatology, University of WashingtonDivision of Rheumatology, University of WashingtonDivision of Rheumatology, University of WashingtonAbstract Background Most patients with systemic lupus erythematosus (SLE) have IgG autoantibodies against the RNA-binding p40 (ORF1p) protein encoded by the L1 retroelement. This study tested if these autoantibodies are also present in children with pediatric SLE (pSLE) and if the p40 protein itself could be detected in immune cells. Methods Autoantibodies in the plasma of pSLE patients (n = 30), healthy children (n = 37), and disease controls juvenile idiopathic arthritis (JIA) (n = 32) and juvenile dermatomyositis (JDM) (n = 60), were measured by ELISA. Expression of p40 in immune cells was assessed by flow cytometry. Markers of neutrophil activation and death were quantitated by ELISA. Results IgG and IgA autoantibodies reactive with p40 were detected in the pSLE patients, but were low in healthy controls and in JIA or JDM. pSLE patients with active disease (13 of them newly diagnosed) had higher titers than the same patients after effective therapy (p = 0.0003). IgG titers correlated with SLEDAI (r = 0.65, p = 0.0001), ESR (r = 0.43, p = 0.02), and anti-dsDNA antibodies (r = 0.49, p < 0.03), and inversely with complement C3 (r = -0.55, p = 0.002) and C4 (r = -0.51, p = 0.006). p40 protein was detected in a subpopulation of CD66b+ granulocytes in pSLE, as well as in adult SLE patients. Myeloperoxidase and neutrophil elastase complexed with DNA and the neutrophil-derived S100A8/A9 were elevated in plasma from pSLE patients with active disease and correlated with anti-p40 autoantibodies and disease activity. Conclusions Children with active SLE have elevated IgG and IgA autoantibodies against L1 p40, and this protein can be detected in circulating granulocytes in both pediatric and adult SLE patients. P40 expression and autoantibody levels correlate with disease activity. Markers of neutrophil activation and death also correlate with these autoantibodies and with disease activity, suggesting that neutrophils express L1 and are a source of p40.https://doi.org/10.1186/s13075-021-02538-3Pediatric lupus erythematosusLong interspersed nuclear elementRetrotransposonAutoantibodiesNeutrophils
collection DOAJ
language English
format Article
sources DOAJ
author Kennedy C. Ukadike
Kathryn Ni
Xiaoxing Wang
Martin S. Taylor
John LaCava
Lauren M. Pachman
Mary Eckert
Anne Stevens
Christian Lood
Tomas Mustelin
spellingShingle Kennedy C. Ukadike
Kathryn Ni
Xiaoxing Wang
Martin S. Taylor
John LaCava
Lauren M. Pachman
Mary Eckert
Anne Stevens
Christian Lood
Tomas Mustelin
IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
Arthritis Research & Therapy
Pediatric lupus erythematosus
Long interspersed nuclear element
Retrotransposon
Autoantibodies
Neutrophils
author_facet Kennedy C. Ukadike
Kathryn Ni
Xiaoxing Wang
Martin S. Taylor
John LaCava
Lauren M. Pachman
Mary Eckert
Anne Stevens
Christian Lood
Tomas Mustelin
author_sort Kennedy C. Ukadike
title IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
title_short IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
title_full IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
title_fullStr IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
title_full_unstemmed IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
title_sort igg and iga autoantibodies against l1 orf1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus
publisher BMC
series Arthritis Research & Therapy
issn 1478-6362
publishDate 2021-05-01
description Abstract Background Most patients with systemic lupus erythematosus (SLE) have IgG autoantibodies against the RNA-binding p40 (ORF1p) protein encoded by the L1 retroelement. This study tested if these autoantibodies are also present in children with pediatric SLE (pSLE) and if the p40 protein itself could be detected in immune cells. Methods Autoantibodies in the plasma of pSLE patients (n = 30), healthy children (n = 37), and disease controls juvenile idiopathic arthritis (JIA) (n = 32) and juvenile dermatomyositis (JDM) (n = 60), were measured by ELISA. Expression of p40 in immune cells was assessed by flow cytometry. Markers of neutrophil activation and death were quantitated by ELISA. Results IgG and IgA autoantibodies reactive with p40 were detected in the pSLE patients, but were low in healthy controls and in JIA or JDM. pSLE patients with active disease (13 of them newly diagnosed) had higher titers than the same patients after effective therapy (p = 0.0003). IgG titers correlated with SLEDAI (r = 0.65, p = 0.0001), ESR (r = 0.43, p = 0.02), and anti-dsDNA antibodies (r = 0.49, p < 0.03), and inversely with complement C3 (r = -0.55, p = 0.002) and C4 (r = -0.51, p = 0.006). p40 protein was detected in a subpopulation of CD66b+ granulocytes in pSLE, as well as in adult SLE patients. Myeloperoxidase and neutrophil elastase complexed with DNA and the neutrophil-derived S100A8/A9 were elevated in plasma from pSLE patients with active disease and correlated with anti-p40 autoantibodies and disease activity. Conclusions Children with active SLE have elevated IgG and IgA autoantibodies against L1 p40, and this protein can be detected in circulating granulocytes in both pediatric and adult SLE patients. P40 expression and autoantibody levels correlate with disease activity. Markers of neutrophil activation and death also correlate with these autoantibodies and with disease activity, suggesting that neutrophils express L1 and are a source of p40.
topic Pediatric lupus erythematosus
Long interspersed nuclear element
Retrotransposon
Autoantibodies
Neutrophils
url https://doi.org/10.1186/s13075-021-02538-3
work_keys_str_mv AT kennedycukadike iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT kathrynni iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT xiaoxingwang iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT martinstaylor iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT johnlacava iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT laurenmpachman iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT maryeckert iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT annestevens iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT christianlood iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
AT tomasmustelin iggandigaautoantibodiesagainstl1orf1pexpressedingranulocytescorrelatewithgranulocyteconsumptionanddiseaseactivityinpediatricsystemiclupuserythematosus
_version_ 1721419960799985664